medigraphic.com

2018, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (3)

Characterization of chronic clinical manifestations in patients with chikungunya fever

Sosa-Martínez MJ, Orea-Flores M, Vázquez-Cruz I, Palacios-Castillo V, Juanico-Morales G, Pérez-Mijangosa L

Language: Spanish
References: 44
Page: 239-245
PDF size: 845.85 Kb.


ABSTRACT

Background: In Mexico there are no studies concerning the chronicity of clinical manifestations of chikungunya fever (CHIK).
Objective: To describe the characterization of chronic clinical manifestations in patients with chikungunya fever from the Unidad de Medicina Familiar No.9 (UMF No. 9).
Methods: A longitudinal, ambispective study was performed in a cohort of 116 patients with positive serology of CHIK, confirmed by RTPCR or IGM test performed at UMF No. 9 of Acapulco, Guerrero, from December 2014 to January 2017. The population was obtained from the epidemiological surveillance platform. The source of information was the epidemiological study of cases for vector-borne diseases. With measurements at 3, 4, 5, 6, 12 and 18 months of the onset of the acute phase, data were captured and analyzed in the statistical package SPSS, version 23.
Results: 62% of patients presented chronicity at 3 months; arthralgia was the most frequent chronic symptom with 88.8%; female gender and the age group of 20-59 years were the most affected.
Conclusions: Even though more than half of our population presented CHIK chronicity, this was lower than the reports from international literature; the main symptoms reported during the chronic phase were arthralgias and fatigue. The knowledge of CHIK symptoms behavior provides standards to generate integral management guides with a holistic and multidisciplinary approach.


REFERENCES

  1. Fundación del Español Urgente (Fundéu). Chikunguña, con minúscula y Con eñe. 01072014. Disponible en https://www.fundeu.es/recomendacion/chikungunaadaptacion- de-chikungunya/ [Consultado el 19 de diciembre de 2014]. 2

  2. Ministerio de Salud Pública (Santo Domingo, República Dominicana). Comisión Nacional de Expertos para la Atención Clínica al Chikungunya. Guía de manejo clínico para la infección por el virus chikungunya (CHIKV). Mayo de 2014. Disponible en http://www1.paho.org/dor/images/stories/archivos/chikungu nya/guia_chikv2.pdf?u a=1&ua=1 [Consultado el 17 de agosto de 2014].

  3. Instituto de Salud Pública de Chile. Departamento de Asuntos Científicos. Boletín laboratorio y vigilancia al día 2012; 7. Disponible en http://www.ispch.cl/sites/default/files/BOLETIN%207.PDF [Consultado el 17 de agosto de 2014].

  4. Rey JR, Connelly CR, Mores CN, Smartt CT, Tabachinick WJ. La Fiebre Chikungunya. University of Florida. The Institute of Food and Agricultural Sciences. Disponible en http://edis.ifas.ufl.edu/pdffiles/IN/IN72900.pdf [Consultado el 25 de septiembre de 2012].

  5. Pan American Health Organization/Centers for Disease Control and Prevention. Preparedness and response for Chikungunya Virus. Response in the Americas. Washington, DC: PAHO; 2011. Disponible en http:/www.paho.org/hq/index.php?option=com_docman&tas k=doc_download&gid=16984&Itemid=&lang=en

  6. Martin-Farfán AM, Calbo-Torrecillas F, Pérez de Pedro I. Fiebre importada por el virus de Chikungunya. Enferm Infecc Microbiol Clin. 2008;26(6):343-4.

  7. Frías-Salcedo JA. Aspectos clínico epidemiológicos de la infección por Virus Chikungunya. Enf Inf Microbiol. 2014;34(4):149-54. Disponible en http://www.medigraphic.com/pdfs/micro/ei-2014/ei144f.pdf

  8. Martínez FN, González LJ, Fino G, Rossi L, Troncoso A. Amenaza del virus Chikungunya: la globalización de las enfermedades transmitidas por insecto vector. Pren Méd Argent 2009; 96:671-80.

  9. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955 Jan;49(1):28- 32.

  10. Lumsden WH. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg. 1955 Jan;49(1):33-57.

  11. Ministerio de Salud (Perú). Guía de práctica clínica para la atención de casos de fiebre chikungunya en el Perú. Lima, Perú: Dirección General de Salud de las Personas, Ministerio de Salud; 2015. Disponible en http://bvs.minsa.gob.pe/local/minsa/3280.pdf

  12. Instituto Mexicano del Seguro Social. Prevención, diagnóstico y tratamiento de la infección por el virus chikungunya. México: Instituto Mexicano del Seguro Social; 2 de julio de 2015. Disponible en http://www.cenetec.salud.gob.mx/interior/catalogoMaestroG PC.html

  13. Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007; 88:2363-77.

  14. Organización Mundial de la Salud (OMS)/Organización Panamericana de la Salud (OPS). Actualización epidemiológica. Fiebre por Chikungunya. OMS/OPS; 23 de mayo de 2014. Disponible en https://www.paho.org/hq/dmdocuments/2014/2014-may-23- cha-chik-actualizacion-epi.pdf

  15. Centro Nacional de Información de Ciencias Médicas (Cuba). Fiebre Chikungunya. Enfermedad emergente y transmisible. La Habana: Infomed; c1999-2014 [actualizado el 24 de julio de 2014] Disponible en http://temas.sld.cu/chikungunya/2014/08/11/fiebrechikungunya- en-el-caribe/ [Consultado el 17 de agosto de 2014].

  16. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikingunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319-27.

  17. Organización Panamericana de la Salud. Preparación y respuesta ante la eventual introducción del virus Chikungunya en las Américas. Washington, DC; 2011. OPS. Disponible en https://www.medbox.org/public-health- 4/preparacion-y-respuesta-ante-la-eventual-introducciondel- virus-chikungunya-en-lasamericas/ toolboxes/preview?q= [Consultado el 3 de junio 4 de 2014].

  18. Rivera-Ávila RC. Fiebre chikungunya en México: caso confirmado y apuntes para su vigilancia epidemiológica. Salud Publica Mex. 2014;56:402-4.

  19. Instituto Mexicano del Seguro Social. Estadísticas epidemiológicas del Instituto Mexicano del Seguro Social. Delegación estatal Guerrero. Acapulco, Guerrero: IMSS; 2015.

  20. Organización Panamericana de la Salud (OPS). Zoonosis y enfermedades transmisibles comunes al hombre y los animales: Clamidiasis, rickettsiosis y virosis. 3° ed. Vol II. Washington, DC: OPS; 2003. Publicación científica y técnica N° 580. p. 240-51.

  21. Lakshmi V, Neeraja M, Subbalaxmi MV, Parida MM, Dash PK, Santhosh SR, et al. Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin Infect Dis. 2008;46:1436-42.

  22. Lemant J, Boisson V, Winer A, Thibault L, André H, Tixier F, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005- 2006. Crit Care Med. 2008;36(9):2536-41.

  23. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg. 2007;77(4):727-31.

  24. Gerardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med. 2008; 5(3):e60.

  25. Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikunyunga virus infecction: An overview. New Microbiol. 2013;36(3):211-27.

  26. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al.; CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007 Dec 1;370(9602):1840-6.

  27. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3:e389.

  28. Hoarau JJ, Jaffar Bandjee MC, Kreibich Trotot P, Das T, Li- Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914-27.

  29. Bouquillard E, Combe B. Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis. 2009;68(9):1505-6.

  30. Porta L. Fiebre Chikungunya Amenaza para la Región de América. Salud Militar. 2012;31(1):25-33.

  31. Pimentel R, Skewes-Ramm, Moya J. Chikungunya en la República Dominicana: lecciones aprendidas en los primeros seis meses. Rev Panam Salud Pública. 2014;36(5):336-41.

  32. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi A, Leroy E. The Acute Phase of Chikungunya Virus Infection in Humans Is Associated With Strong Innate Immunity and T CD8 Cell Activation d. J Infect Dis. 2011 Jul 1;204(1):115- 23.

  33. Soumahoro MK, Gerardin P, Boelle PY, Perrau J, Fianu A, Pouchot J, et al. Impact of Chikungunya virus infection on health status and quality of life:a retrospective cohort study. PLoS One. 2009; 4(11):e7800.

  34. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010;104(6):392-9.

  35. Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J. 1983;63(9):313-5.

  36. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008 Aug 15; 47(4):469-75.

  37. Rodriguez-Morales AJ, Villamil-Gomez W, Merlano- Espinosa M, Simone-Kleber L. Post-chikungunya chronic arthralgia: a first retrospective follow-up study of 39 cases in Colombia. Clin Rheumatol. 2016 Mar;35(3):831-2.

  38. Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg. 2008;78(2):333-7.

  39. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J. 2013 Aug;89(1054):440-7.

  40. Carey DE. Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci. 1971; 26(1):243-62.

  41. Queyriaux B, Simon F, Grandadam M, Michel R, Tolou H, Boutin JP. Clinical burden of chikungunya virus infection. Lancet Infect Dis. Jan 2008;8(1):2-3.

  42. Chopra A, Saluja M, Venugopalan A. Effectiveness of 6 chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014;66(2):319-26.

  43. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. Chikungunya Disease: Infection-Associated Markers from the Acute to the Chronic Phase of Arbovirus- Induced Arthralgia. PLoS Negl Trop Dis. 2012;6(3):e1446.

  44. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep;69(9):1580-8.




2020     |     www.medigraphic.com